1981 studies found for:    HIV [CONDITION] AND NIH [SPONSOR-COLLABORATORS-CLASS] NOT NIMH [ORGANIZATION-NAME]
Show Display Options
Rank Status Study
21 Completed C2P (With Venues): Connect to Protect® Partnerships For Youth Prevention Interventions
Condition: HIV Infections
Intervention: Behavioral: Community Mobilization
22 Completed Connect to Protect Partnerships for Youth Prevention Interventions: Phase II
Condition: HIV Infection
Intervention:
23 Completed C2P Mobilization Intervention (Pilot)
Condition: HIV Infections
Intervention: Behavioral: Community Mobilization
24 Completed Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV vCP1521;   Biological: ALVAC HIV-1 vCP1521
25 Completed Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections
Conditions: HIV Infections;   Mycobacterium Infections;   Tuberculosis
Intervention: Drug: thalidomide
26 Completed Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth
Condition: HIV Infection
Intervention:
27 Recruiting Brain Imaging for HIV-Associated Thinking and Mood Disorders
Conditions: Human Immunodeficiency Virus;   Neurocognitive Impairment
Intervention:
28 Completed Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
Conditions: HIV Infection;   Hepatitis B
Intervention:
29 Completed Friendship Based HIV/STI (Sexually Transmitted Infections) Intervention for African American Females
Conditions: Sexual Behavior;   Sexually Transmitted Diseases;   HIV Infections
Intervention: Behavioral: Project ÒRÉ
30 Completed Intervention for Newly Diagnosed Youth With HIV
Condition: HIV
Intervention: Behavioral: "Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT)
31 Completed Pre-Exposure Prophylaxis in YMSM
Condition: HIV
Interventions: Drug: coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP;   Drug: Placebo;   Behavioral: Many Men, Many Voices (3MV)
32 Completed Microbicides Acceptability Among Sexually Active Young Women
Condition: HIV Infections
Intervention: Behavioral: Automated diary system
33 Completed A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Biological: MN rgp120/HIV-1 and GNE8 rgp120/HIV-1;   Biological: ALVAC-HIV MN120TMG (vCP205)
34 Completed HIV Treatment-Readiness Measure (HTRM) Validation
Condition: HIV Infections
Intervention:
35 Completed Intervention Development for Newly Diagnosed Youth With HIV
Condition: HIV
Intervention:
36 Recruiting Enhancement of Connect to Protect® (C2P)
Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
37 Completed Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
Condition: HIV Infections
Interventions: Drug: Erythromycin;   Drug: Nevirapine;   Drug: Ampicillin sodium;   Drug: Metronidazole
38 Unknown  Engaging Care for HIV-Infected Adolescent Females.
Condition: HIV Infection
Intervention:
39 Completed Typology of Adherence in Adolescents: Phase II
Condition: HIV Infection
Intervention:
40 Completed PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir
Condition: HIV Infections
Intervention: Procedure: blood draw

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years